PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 10343626

  • 1. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
    Wilson AM, Lipworth BJ.
    Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
    [Abstract] [Full Text] [Related]

  • 2. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
    Wilson AM, McFarlane LC, Lipworth BJ.
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
    [Abstract] [Full Text] [Related]

  • 3. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ, Clark DJ, McFarlane LC.
    Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
    [Abstract] [Full Text] [Related]

  • 4. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
    Wilson AM, Clark DJ, McFarlane L, Lipworth BJ.
    Eur J Clin Pharmacol; 1997 Aug; 53(1):33-7. PubMed ID: 9349927
    [Abstract] [Full Text] [Related]

  • 5. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
    Wilson AM, Clark DJ, Devlin MM, McFarlane LC, Lipworth BJ.
    Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
    [Abstract] [Full Text] [Related]

  • 6. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ, Lipworth BJ.
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [Abstract] [Full Text] [Related]

  • 7. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
    Skoner DP, Gentile D, Angelini B, Kane R, Birdsall D, Banerji D.
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
    [Abstract] [Full Text] [Related]

  • 8. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
    Clark DJ, Clark RA, Lipworth BJ.
    Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
    [Abstract] [Full Text] [Related]

  • 9. Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment.
    Wilson AM, Sims EJ, Lipworth BJ.
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):329-35. PubMed ID: 10435058
    [Abstract] [Full Text] [Related]

  • 10. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis.
    Wilson AM, Sims EJ, McFarlane LC, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):598-604. PubMed ID: 9802367
    [Abstract] [Full Text] [Related]

  • 11. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.
    Wilson AM, McFarlane LC, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):470-4. PubMed ID: 9564799
    [Abstract] [Full Text] [Related]

  • 12. Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults.
    Wilson AM, Brewster HJ, Lipworth BJ.
    J Allergy Clin Immunol; 1998 Nov; 102(5):751-6. PubMed ID: 9819291
    [Abstract] [Full Text] [Related]

  • 13. Effect of intranasal fluticasone propionate and triamcinolone acetonide on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity in healthy volunteers.
    Bachert C, Lukat KF, Lange B.
    Clin Exp Allergy; 2004 Jan; 34(1):85-90. PubMed ID: 14720267
    [Abstract] [Full Text] [Related]

  • 14. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
    Clark DJ, Grove A, Cargill RI, Lipworth BJ.
    Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
    [Abstract] [Full Text] [Related]

  • 15. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
    Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
    Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
    [Abstract] [Full Text] [Related]

  • 16. Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers.
    Wilson AM, McFarlane LC, Lipworth BJ.
    J Clin Endocrinol Metab; 1998 Mar; 83(3):922-5. PubMed ID: 9506749
    [Abstract] [Full Text] [Related]

  • 17. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
    Dempsey OJ, Wilson AM, Coutie WJ, Lipworth BJ.
    Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
    [Abstract] [Full Text] [Related]

  • 19. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 20. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
    Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.